GalbraithWight host symposium, ‘Pricing Innovation for New Therapies in Advanced Cancers: Addressing Affordability and the Practical Application of Innovative Pricing Methods’ on Sunday 17th May, 6:30 – 7:30 pm EDT at the ISPOR 20th International Meeting 16th – 20th May, Philadelphia, PA, USA.
Click here to find out more. Visit us at our ISPOR exhibition.
Chief Executive, Colin Wight presents ‘Things that go horribly wrong in the practice of Market Access... and how to avoid them’ and chairs the afternoon of day two of the Pharma Pricing and Market Access Outlook, Congress 2015, 24 – 26th February 2015. Visit our exhibition at Stand 3. Click here to find out more
GalbraithWight exhibit at the ISPOR 17th Annual European Congress, 8th – 12th November 2014, Amsterdam, The Netherlands. Click here to find out more. Visit us at our ISPOR exhibition stands 512 and 513.
GalbraithWight sponsor and exhibit at the Heath Technology Assessment International (HTAi) 11th Annual Meeting, 16th – 18th June 2014, Washington DC, USA. Visit us at our exhibition at stand 3. Click here to find out more.
GalbraithWight exhibit at the ISPOR 19th International Meeting 31st May – 4th June 2014, Montreal, Canada. Click here to find out more. Visit us at our ISPOR exhibition at stands 84 and 85.
GalbraithWight open new USA office in Princeton, New Jersey, USA.
Chief Executive, Colin Wight presents ‘7 unforced errors in the implementation of market access by Pharma companies’ and chairs the afternoon of day two of the Pharma Pricing and Market Access Outlook, Europe 2014, 25th – 26th February 2014 - click here to find out more and click here to view the presentation
GalbraithWight host symposium at the ISPOR 16th Annual European Congress, 2nd – 6th November 2013, Dublin, Ireland ‘Building, embedding & optimising market access capabilities – from strategy to execution’ - click here to find out more and click here to view the presentation
Chief Executive, Colin Wight presents ‘7 unforced errors in the implementation of market access by Pharma companies’ and Chairs the ‘Evidence generation to support Market Access’ stream of day two of the Market Access World USA Conference, 23rd – 24th October 2013 in Boston, USA – click here to find out more and click here to view the presentation
Chief Executive, Colin Wight presents ‘Three Vital Areas for Improving Market Access – for Industry & Payers’ and chairs day two of the PharmAccess Leaders Forum, 16th – 18th October, Berlin, Germany – click here to find out more and click here to view the presentation
GalbraithWight Principal Consultant Emerging Markets, Taufi Ryder and Chief Executive Colin Wight co-author ‘Building and delivering market access capabilities’ article in the July 2013 edition of Pharmaceutical Marketing Europe discussing the need to develop market access skills and capabilities in Emerging Markets if their potential for growth is to be realised by the global Pharma business - download the article / read online
Colin Wight, Chief Executive to speak at the Pharma Pricing and Market Access World Europe 2013 event, London, 20th - 21st March 2013 - click here to find out more
Colin Wight, CEO Chairs Market Access conference, Boston, MA, USA, October 2012 - click here to find out more
Colin Wight, CEO, speaks at Market Access conference, London March 2012 - click here to view the presentation
